Evidence map›Paper›PMID 31214565›Full record

ArticleFrontiers in chemistry2019

Discovery of Potential Anti-infective Therapy Targeting Glutamine Synthetase in

Wen-Qiang Cui, Qian-Wei Qu, Jin-Peng Wang, Jing-Wen Bai, God'spower Bello-Onaghise, Yu-Ang Li, Yong-Hui Zhou, Xing-Ru Chen, Xin Liu, Si-Di Zheng and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Bacillibactin, a PotentialInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Antibiotics (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. UsingFrontiers in pharmacology · 2022
    Review
  8. Article
  9. Article
  10. Inactivation of Glutamine Synthetase-Coding GeneFrontiers in microbiology · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Wen-Qiang CuiCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Qian-Wei QuCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Jin-Peng WangCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Jing-Wen BaiCollege of Science, Northeast Agricultural University, Harbin, China.
God'spower Bello-OnaghiseCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Yu-Ang LiCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Yong-Hui ZhouCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Xing-Ru ChenCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Xin LiuCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Si-Di ZhengCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Xiao-Xu XingCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Nsabimana EliphazCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Yan-Hua LiCollege of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
Northeast Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutamine synthetase (GS), which catalyzes the production of glutamine, plays essential roles in most biological growth and biofilm formation, suggesting that GS may be used as a promising target for antibacterial therapy. We asked whether a GS inhibitor could be found as an anti-infective agent of

Indexed as

anti-infectiveglutamine synthetasemastitismolecular dockingsorafenib

Identifiers

PMID31214565
PMCPMC6558069
OpenAlexW2948776191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.